 | ENDOMETRIOSIS: EMERGING RESEARCH AND INTERVENTION STRATEGIES
Copyright © 2002 by the New York Academy of Sciences
description
Annals of the New York Academy of Sciences 955:119-138 (2002)
© 2002 New York Academy of Sciences
Circulating Ovarian Steroids and Endometrial Matrix Metalloproteinases (MMPs)
PATRICK HENRIETa,
PATRICIA B. CORNETa,
PASCALE LEMOINEa,
CHRISTINE GALANTa,b,
CHRISTIAN F. SINGERa,c,
PIERRE J. COURTOYa,
YVES EECKHOUTa AND
ETIENNE MARBAIXa,b
aCell Biology Unit, Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, Brussels, Belgium
bDepartment of Pathology, Saint Luc University Clinics, Université Catholique de Louvain, Brussels, Belgium
Address for correspondence: Etienne Marbaix, Department of Pathology, Saint Luc University Clinics, Université Catholique de Louvain, Avenue Hippocrate, 10, B-1200 Brussels, Belgium. Voice: +32 2 764 1784; fax: +32 2 764 8924.
marbaix{at}cell.ucl.ac.be
cPresent address: Christian F. Singer, Division of Special Gynecology, Department of Obstetrics and Gynecology, University of Vienna, Vienna, Austria.
Recent studies strongly suggest that matrix metalloproteinases (MMPs) play a key role in the initiation of menstrual bleeding in the human endometrium upon the fall of ovarian steroid serum concentrations by inducing the degradation of the extracellular matrix of this mucosa. MMPs are also involved in abnormal endometrial bleeding and have been identified in endometriotic foci. In all cases, they are associated with areas of extracellular matrix breakdown. This paper reviews the literature on the regulation by estradiol and progesterone of the expression and activation of MMPs, and of the expression of their tissue inhibitors (TIMPs), (i) in the endometrium in situ during normal cycle, (ii) during artificial cycles in spayed monkeys, and (iii) in cultures of endometrial explants or purified cells. Whereas progesterone consistently decreases the activity of endometrial MMPs, its effects vary in intensity, duration, and pattern between MMPs as well as among experimental systems. The contribution and limitations of the various investigations are therefore discussed. The focal heterogeneity points to additional local controls of the expression and activation of MMPs in human endometrium, acting beyond the general inhibitory role of progesterone, for example, by cytokines. Focal changes in type or abundance of sex steroid receptors also could be responsible for spatial variation in the expression of MMPs in the endometrium and endometriotic lesions.
Key Words: endometrium • estradiol • progesterone • matrix metalloproteinases • tissue inhibitors
This article has been cited by other articles:
|
|
|
|
 
H. P. Gaide Chevronnay, P. B. Cornet, D. Delvaux, P. Lemoine, P. J. Courtoy, P. Henriet, and E. Marbaix
Opposite Regulation of Transforming Growth Factors-{beta}2 and -{beta}3 Expression in the Human Endometrium
Endocrinology,
March 1, 2008;
149(3):
1015 - 1025.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-J. Chang, T.-Y. Wang, Y.-H. Lee, and C.-J. Tai
Extracellular ATP activates nuclear translocation of ERK1/2 leading to the induction of matrix metalloproteinases expression in human endometrial stromal cells
J. Endocrinol.,
June 1, 2007;
193(3):
393 - 404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Vassilev, C. M. Pretto, P. B. Cornet, D. Delvaux, Y. Eeckhout, P. J. Courtoy, E. Marbaix, and P. Henriet
Response of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Messenger Ribonucleic Acids to Ovarian Steroids in Human Endometrial Explants Mimics Their Gene- and Phase-Specific Differential Control in Vivo
J. Clin. Endocrinol. Metab.,
October 1, 2005;
90(10):
5848 - 5857.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Hudelist, H. Lass, J. Keckstein, I. Walter, F. Wieser, R. Wenzl, R. Mueller, K. Czerwenka, E. Kubista, and C.F. Singer
Interleukin 1{alpha} and tissue-lytic matrix metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis
Hum. Reprod.,
June 1, 2005;
20(6):
1695 - 1701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. B. Cornet, C. Galant, Y. Eeckhout, P. J. Courtoy, E. Marbaix, and P. Henriet
Regulation of Matrix Metalloproteinase-9/Gelatinase B Expression and Activation by Ovarian Steroids and LEFTY-A/Endometrial Bleeding-Associated Factor in the Human Endometrium
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
1001 - 1011.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. BISCHOFF and J. L. SIMPSON
Genetic Basis of Endometriosis
Ann. N.Y. Acad. Sci.,
December 1, 2004;
1034(1):
284 - 299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. W. Nap, G. A.J. Dunselman, A. F.P.M. de Goeij, J. L.H. Evers, and P. G. Groothuis
Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model
Hum. Reprod.,
October 1, 2004;
19(10):
2180 - 2187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Goffin, C. Munaut, F. Frankenne, S. Perrier d'Hauterive, A. Beliard, V. Fridman, P. Nervo, A. Colige, and J.-M. Foidart
Expression Pattern of Metalloproteinases and Tissue Inhibitors of Matrix-Metalloproteinases in Cycling Human Endometrium
Biol Reprod,
September 1, 2003;
69(3):
976 - 984.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. B. Cornet, C. Picquet, P. Lemoine, K. G. Osteen, K. L. Bruner-Tran, S. Tabibzadeh, P. J. Courtoy, Y. Eeckhout, E. Marbaix, and P. Henriet
Regulation and Function of LEFTY-A/EBAF in the Human Endometrium. mRNA EXPRESSION DURING THE MENSTRUAL CYCLE, CONTROL BY PROGESTERONE, AND EFFECT ON MATRIX METALLOPROTEINASES
J. Biol. Chem.,
November 1, 2002;
277(45):
42496 - 42504.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
